Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Mycophenolate mofetil/rituximab/romiplostim

Treatment failure

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tan MM, et al. Eltrombopag Causes Cell Cycle Arrest of T Cells through Iron Chelation and Could Modulate the Immune Response in ITP. Blood 140 (Suppl. 1): 5562-5563, Nov 2022. Available from: URL: https://dx.doi.org/10.1182/blood-2022-170449 [abstract] Tan MM, et al. Eltrombopag Causes Cell Cycle Arrest of T Cells through Iron Chelation and Could Modulate the Immune Response in ITP. Blood 140 (Suppl. 1): 5562-5563, Nov 2022. Available from: URL: https://​dx.​doi.​org/​10.​1182/​blood-2022-170449 [abstract]
Metadaten
Titel
Mycophenolate mofetil/rituximab/romiplostim
Treatment failure
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55744-6

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Paliperidone

Case report

Dexamethasone

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Methotrexate